Literature DB >> 9463979

The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial.

W Stalman1, G A van Essen, Y van der Graaf, R A de Melker.   

Abstract

BACKGROUND: Acute sinusitis-like complaints are very common and are usually treated with antibiotics in spite of the lack of evidence for the effectiveness of antibiotic therapy and the increasing number of resistant strains. AIM: To assess the effectiveness of doxycycline in adults with acute sinusitis-like complaints in general practice.
METHOD: The effects of doxycycline in a placebo-controlled, double-blind, randomized trial were assessed in adults consulting their general practitioner (GP) with complaints after a common cold or influenza, pain in the head when bending forward, purulent nasal discharge, predominantly unilateral maxillary pain, toothache, or pain when chewing. Primary outcome events were the resolution of facial pain and the resumption of daily activities. Treatment differences were assessed by means of Kaplan-Meier curves and hazard ratios. The follow-up period was 42 days.
RESULTS: No significant difference was found in time to recover between the doxycycline-treated group and the placebo-treated group. However, the adjusted hazard ratio for the group receiving doxycycline was 1.17 (95% CI = 0.87-1.57) for the resolution of pain and 1.31 (95% CI = 0.96-1.78) for the resumption of daily activities. After 10 days, 85% of all patients reported improvement and 60% were completely cured. Side effects were reported by 17% of the doxycycline-treated group, with two patients withdrawing because of side effects.
CONCLUSIONS: Data from this study indicate that doxycycline does not add to the effectiveness of decongestive nose drops and steam inhalation in treating acute sinusitis-like complaints in general practice adults.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9463979      PMCID: PMC1410064     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  31 in total

Review 1.  First-line management of sinusitis: a national problem? Overview.

Authors:  D W Kennedy
Journal:  Otolaryngol Head Neck Surg       Date:  1990-11       Impact factor: 3.497

2.  Sinusitis of the maxillary antrum.

Authors:  F O Evans; J B Sydnor; W E Moore; G R Moore; J L Manwaring; A H Brill; R T Jackson; S Hanna; J S Skaar; L V Holdeman; S Fitz-Hugh; M A Sande; J M Gwaltney
Journal:  N Engl J Med       Date:  1975-10-09       Impact factor: 91.245

3.  Endoscopic endonasal surgery--concepts in treatment of recurring rhinosinusitis. Part I. Anatomic and pathophysiologic considerations.

Authors:  H Stammberger
Journal:  Otolaryngol Head Neck Surg       Date:  1986-02       Impact factor: 3.497

4.  Analysis of symptoms and clinical signs in the maxillary sinus empyema.

Authors:  O Berg; C Carenfelt
Journal:  Acta Otolaryngol       Date:  1988 Mar-Apr       Impact factor: 1.494

5.  [A study of spontaneous cure of sinusitis (author's transl)].

Authors:  W Mann; I Jonas
Journal:  HNO       Date:  1981-03       Impact factor: 1.284

6.  The McGill Pain Questionnaire: major properties and scoring methods.

Authors:  Ronald Melzack
Journal:  Pain       Date:  1975-09       Impact factor: 6.961

7.  Local hyperthermia benefits natural and experimental common colds.

Authors:  D Tyrrell; I Barrow; J Arthur
Journal:  BMJ       Date:  1989-05-13

8.  A method for assessing the quality of a randomized control trial.

Authors:  T C Chalmers; H Smith; B Blackburn; B Silverman; B Schroeder; D Reitman; A Ambroz
Journal:  Control Clin Trials       Date:  1981-05

9.  Bacteriology of maxillary sinusitis in relation to character of inflammation and prior treatment.

Authors:  O Berg; C Carenfelt; G Kronvall
Journal:  Scand J Infect Dis       Date:  1988

10.  A comparative trail of doxycycline ('Vibramycin') and ampicillin in the treatment of acute sinusitis.

Authors:  O G Agbim
Journal:  Curr Med Res Opin       Date:  1974       Impact factor: 2.580

View more
  22 in total

1.  Antibiotics for acute sinusitis in general practice. Entry criteria were too dissimilar for studies to be combined for meta-analysis.

Authors:  G G Browning
Journal:  BMJ       Date:  1999-06-12

2.  Acute sinusitis and antibiotic treatment.

Authors:  M Lindbaek; P Hjortdahl
Journal:  Br J Gen Pract       Date:  1998-06       Impact factor: 5.386

3.  Systemic corticosteroid monotherapy for clinically diagnosed acute rhinosinusitis: a randomized controlled trial.

Authors:  Roderick P Venekamp; Marc J M Bonten; Maroeska M Rovers; Theo J M Verheij; Alfred P E Sachs
Journal:  CMAJ       Date:  2012-08-07       Impact factor: 8.262

Review 4.  Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review.

Authors:  Jakob M Burgstaller; Johann Steurer; David Holzmann; Gabriel Geiges; Michael B Soyka
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-18       Impact factor: 2.503

5.  [Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery].

Authors:  B A Stuck; A Beule; D Jobst; L Klimek; M Laudien; M Lell; T J Vogl; U Popert
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

Review 6.  Sinusitis (acute).

Authors:  Kim Ah-See
Journal:  BMJ Clin Evid       Date:  2011-12-21

7.  Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis.

Authors:  S D de Ferranti; J P Ioannidis; J Lau; W V Anninger; M Barza
Journal:  BMJ       Date:  1998-09-05

Review 8.  Acute rhinosinusitis : a pharmacoeconomic review of antibacterial use.

Authors:  Jean-Blaise Wasserfallen; Françoise Livio; Giorgio Zanetti
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 9.  Sinusitis (acute).

Authors:  Kim Ah-See
Journal:  BMJ Clin Evid       Date:  2008-03-10

10.  Acute sinusitis: guide to selection of antibacterial therapy.

Authors:  Morten Lindbaek
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.